Broxmeyer H E, Williams D E, Lu L, Cooper S, Anderson S L, Beyer G S, Hoffman R, Rubin B Y
J Immunol. 1986 Jun 15;136(12):4487-95.
The influences of human tumor necrosis factor (TNF) (LuKII), recombinant human TNF-alpha, natural human interferon-gamma (HuIFN-gamma), recombinant HuIFN-gamma, and natural HuIFN-alpha were evaluated alone or in combination for their effects in vitro on colony formation by human bone marrow granulocyte-macrophage (CFU-GM), erythroid (BFU-E), and multipotential (CFU-GEMM) progenitor cells incubated at 5% CO2 in lowered (5%) O2 tension. TNF (LuKII) and recombinant TNF-alpha caused a similar dose-dependent inhibition of colony formation from CFU-GM, BFU-E, and CFU-GEMM. Day 7 CFU-GM colonies were more sensitive than both day 14 CFU-GM colonies and day 7 CFU-GM clusters to inhibition by TNF. BFU-E colonies and CFU-GEMM colonies were least sensitive to inhibition with TNF. The suppressive effects of TNF (LuKII) and recombinant TNF-alpha were inactivated respectively with hetero-anti-human TNF (LuKII) and monoclonal anti-recombinant human TNF-alpha. The hetero-anti-TNF (LuKII) did not inactivate the suppressive effects of TNF-alpha and the monoclonal anti-recombinant TNF-alpha did not inactivate TNF (LuKII). The suppressive effects of TNF did not appear to be mediated via endogenous T lymphocytes and/or monocytes in the bone marrow preparation, and a pulse exposure of marrow cells with TNF for 60 min resulted in maximal or near maximal inhibition when compared with cells left with TNF for the full culture incubation period. A degree of species specificity was noted in that human TNF were more active against human marrow CFU-GM colonies than against mouse marrow CFU-GM colonies. Samples of bone marrow from patients with non-remission myeloid leukemia were set up in the CFU-GM assay and formed the characteristic abnormal growth pattern of large numbers of small sized clusters. These cluster-forming cells were more sensitive to inhibition by TNF than were the CFU-GM colonies and clusters grown from the bone marrow of normal donors. The sensitivity to TNF of colony formation by CFU-GM of patients with acute myelogenous leukemia in partial or complete remission was comparable with that of normal donors. When combinations of TNF and HuIFN were evaluated together, it was noted that TNF (LuKII) or recombinant TNF synergized with natural or recombinant HuIFN-gamma, but not with HuIFN-alpha, to suppress colony formation of CFU-GM, BFU-E, and CFU-GEMM from bone marrow of normal donors at concentrations that had no suppressive effects when molecules were used alone.(ABSTRACT TRUNCATED AT 400 WORDS)
评估了人肿瘤坏死因子(TNF)(LuKII)、重组人TNF-α、天然人干扰素-γ(HuIFN-γ)、重组HuIFN-γ和天然HuIFN-α单独或联合使用时,对在5%二氧化碳和低氧(5%)张力条件下培养的人骨髓粒细胞-巨噬细胞(CFU-GM)、红系(BFU-E)和多能(CFU-GEMM)祖细胞体外集落形成的影响。TNF(LuKII)和重组TNF-α对CFU-GM、BFU-E和CFU-GEMM的集落形成产生了类似的剂量依赖性抑制。第7天的CFU-GM集落比第14天的CFU-GM集落和第7天的CFU-GM细胞簇对TNF抑制更敏感。BFU-E集落和CFU-GEMM集落对TNF抑制最不敏感。TNF(LuKII)和重组TNF-α的抑制作用分别被异种抗人TNF(LuKII)和单克隆抗重组人TNF-α灭活。异种抗TNF(LuKII)未灭活TNF-α的抑制作用,单克隆抗重组TNF-α未灭活TNF(LuKII)。TNF的抑制作用似乎不是通过骨髓制剂中的内源性T淋巴细胞和/或单核细胞介导的,与在整个培养孵育期都接触TNF的细胞相比,骨髓细胞用TNF脉冲暴露60分钟导致最大或接近最大抑制。观察到一定程度的种属特异性,即人TNF对人骨髓CFU-GM集落的活性比对小鼠骨髓CFU-GM集落的活性更高。在CFU-GM测定中设置了非缓解性髓系白血病患者的骨髓样本,其形成了大量小尺寸细胞簇的特征性异常生长模式。这些形成细胞簇的细胞比正常供体骨髓中生长的CFU-GM集落和细胞簇对TNF抑制更敏感。部分或完全缓解的急性髓系白血病患者CFU-GM集落形成对TNF的敏感性与正常供体相当。当评估TNF和HuIFN的联合使用时,注意到TNF(LuKII)或重组TNF与天然或重组HuIFN-γ协同作用,但不与HuIFN-α协同作用,以抑制正常供体骨髓中CFU-GM、BFU-E和CFU-GEMM的集落形成,而这些分子单独使用时在该浓度下无抑制作用。(摘要截短于400字)